Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.

Source:http://linkedlifedata.com/resource/pubmed/id/16492926

Download in:

View as

General Info

PMID
16492926